McKesson (MCK) Stock Overview

Provides healthcare services in the United States and internationally. More details

MCK fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	3/6
Past Performance	5/6
Financial Health	2/6
Dividends	0/6

Rewards

Earnings are forecast to grow 8.67% per year

Earnings grew by 44.5% over the past year

Analysts in good agreement that stock price will rise by 25.4%

Risk Analysis

Shares are highly illiquid

Has a high level of debt

MCK Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

McKesson Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for McKesson
Historical stock prices
Current Share Price	US$658.40
52 Week High	US$691.60
52 Week Low	US$658.40
Beta	0.32
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	2,281.19%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	MCK	DE Healthcare	DE Market
7D	-3.3%	4.1%	0.6%
1Y	n/a	-6.9%	3.8%

Return vs Industry: Insufficient data to determine how MCK performed against the German Healthcare industry.

Return vs Market: Insufficient data to determine how MCK performed against the German Market.

Price Volatility

Is MCK's price volatile compared to industry and market?
MCK volatility
MCK Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.5%
Market Average Movement	5.9%
10% most volatile stocks in DE Market	13.2%
10% least volatile stocks in DE Market	2.8%

Stable Share Price: MCK's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine MCK's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1833	42,300	Brian Tyler	www.mckesson.com

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers.

McKesson Corporation Fundamentals Summary

How do McKesson's earnings and revenue compare to its market cap?
MCK fundamental statistics
Market cap	€76.58b
Earnings (TTM)	€4.15b
Revenue (TTM)	€351.55b

18.5x

P/E Ratio

0.2x

P/S Ratio

Is MCK overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MCK income statement (TTM)
Revenue	US$403.43b
Cost of Revenue	US$388.90b
Gross Profit	US$14.53b
Other Expenses	US$9.77b
Earnings	US$4.76b

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	40.67
Gross Margin	3.60%
Net Profit Margin	1.18%
Debt/Equity Ratio	-780.5%

How did MCK perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

Payout Ratio

Does MCK pay a reliable dividends?

See MCK dividend history and benchmarks

When do you need to buy MCK by to receive an upcoming dividend?
McKesson dividend dates
Ex Dividend Date	Jun 01 2026
Dividend Pay Date	Jul 01 2026
Days until Ex dividend	20 days
Days until Dividend pay date	10 days

Does MCK pay a reliable dividends?

See MCK dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/20 21:30
End of Day Share Price	2026/06/18 00:00
Earnings	2026/03/31
Annual Earnings	2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

McKesson Corporation is covered by 32 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
David Toung	Argus Research Company
Eric Coldwell	Baird
Lawrence Marsh	Barclays